• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Atlantic International Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    6/25/26 8:19:28 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    altn-20260622
    0001605888false00016058882026-06-222026-06-22

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported) June 22, 2026
    ATLANTIC INTERNATIONAL CORP
    (Exact name of registrant as specified in charter)
    Delaware001-4076046-5319744
    (State or other Jurisdiction of
     Incorporation or Organization)
    (Commission File Number)(IRS Employer
     Identification No.)
    270 Sylvan Avenue, Suite 2230
    Englewood Cliffs, NJ
    07632
    (Address of Principal Executive Offices)(zip code)
    (201) 899-4470
    (Registrant’s telephone number, including area code)

    N/A

    (Former name or former address, if changed since last report)
    Securities registered or to be registered as pursuant to Section 12(b) of the Act: None
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
    oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    oSoliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
    oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth companyx
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



    ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

    On June 22, 2026, Atlantic International Corp. (the “Company”) issued a press release announcing its revenue of $249.9 million for the first fiscal quarter ended March 31, 2026. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

    ITEM 7.01. REGULATION FD DISCLOSURE.

    The disclosure in Item 2.02 above is incorporated herein by reference.

    On June 23, 2026, the Company announced that Seven Stars B.V., an entity within the Company’s Circle8 Group’s platform, has been awarded a four-year framework agreement by the Dutch Vehicle Authority for the provision of specialized ICT (Information & Communication Technology) professionals. A copy of the press release announcing the agreement is attached to this Current Report on Form 8-K as Exhibit 99.2.

    The furnishing of the attached press releases is not an admission as to the materiality of any information therein. The information contained in the press releases is summary information that is intended to be considered in the context of more complete information included in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and other public announcements the Company has made and may make from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained in this report, although the Company may do so from time to time as management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures.

    The information in this current report on Form 8-K, including Exhibits 99.1, 99.2 and 99.3, is being furnished and will not be treated as “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.


    ITEM 8.01. OTHER EVENTS.

    On June 23, 2026, Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) notified the Company that, based on the June 22, 2026 filing of the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2026, Nasdaq has determined that the Company is now in compliance with the Nasdaq’s Listing Rule 5250(c)(1) (the “Rule”) and that the matter is now closed.

    A copy of the press release announcing the Company regaining compliance with its filing requirements is attached to this Current Report on Form 8-K as Exhibit 99.3.

    Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
    (d) Exhibits
    Exhibit No.Description
    99.1
    Press release dated June 22, 2026
    99.2
    Press release dated June 23, 2026
    99.3
    Press release dated June 25, 2026
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)

    1


    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    Dated: June 25, 2026
    ATLANTIC INTERNATIONAL CORP.
    By: /s/ Jeffrey Jagid
    Jeffrey Jagid
    Chief Executive Officer
    2
    Get the next $ATLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pfeffer David converted options into 161,290 shares, increasing direct ownership by 10,542% to 162,820 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    3/16/26 6:42:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New insider Franke Guus Paul Wilhelm claimed ownership of 12,516,070 shares (SEC Form 3)

    3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    2/10/26 4:05:29 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Murphy Kevin James

    3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    2/5/26 4:30:02 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:11:34 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:04:40 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:02:59 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    SEC Filings

    View All

    Atlantic International Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    6/25/26 8:19:28 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 424B3 filed by Atlantic International Corp.

    424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    6/24/26 10:45:17 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Atlantic International Corp.

    10-Q - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    6/22/26 6:03:02 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic International Corp Regains Compliance With Nasdaq Listing Requirements

    ENGLEWOOD CLIFFS, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp (NASDAQ:ATLN) ("Atlantic" or the "Company"), a leading global provider of workforce solutions, today announced that it has received formal notification from The Nasdaq Stock Market confirming that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) relating to the timely filing of periodic reports.The notification follows the Company's filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. Nasdaq advised the Company that it now complies with the applicable filing requirements and that the matter has been officially closed. As a result, Atlantic is current wit

    6/25/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International’s Circle8 Secures Minimum $52 Million Government Contract Award

    ENGLEWOOD CLIFFS, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp (NASDAQ:ATLN), a leading provider of workforce solutions, today announced that Seven Stars B.V., a company within its Circle8 Group platform, has been awarded a four-year framework agreement by the Dutch Vehicle Authority (RDW) for the provision of specialized ICT (Information and Communications Technology) professionals. Seven Stars secured the contract through a competitive procurement process involving sixteen participants. Based on the procurement documentation, the framework agreement represents a minimum contract value of approximately $52 million over its four-year term. This award follows Circle

    6/23/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Reports Record First Quarter 2026 Revenue of $249.9 Million

    ENGLEWOOD CLIFFS, N.J., June 22, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN) today reported financial results for the first quarter ended March 31, 2026, and filed its Quarterly Report on Form 10-Q with the Securities and Exchange Commission. The quarter reflects the first contribution of Circle8 Group following the completion of the acquisition on January 23, 2026. The transaction meaningfully expanded Atlantic's geographic reach and operating scale, establishing the Company as a transatlantic workforce solutions platform. The quarter also reflects the initial integration of Circle8 and includes acquisition-related accounting and financing impacts associated with

    6/22/26 8:27:36 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Leadership Updates

    Live Leadership Updates

    View All

    Atlantic International Appoints Gateway Group to Lead Investor Relations Program

    ENGLEWOOD CLIFFS, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, has appointed Gateway Group, a leading strategic corporate and financial communications advisory firm, to lead its investor relations program. Gateway will partner with Atlantic's leadership to strengthen its investor communications strategy and expand engagement within the financial community. The initiative will focus on sharpening the company's messaging and market positioning and expanding outreach to institutional investors and analysts through targeted engagement and conference participation. "Atlantic is entering an

    2/17/26 8:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Strengthens Management Team with Appointment of Kevin J. Murphy as Chief Financial Officer

    ENGLEWOOD CLIFFS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of staffing and workforce solutions, today announced the appointment of Kevin J. Murphy, CPA, as Chief Financial Officer, effective February 2, 2026, as the Company continues to scale its platform and integrate recent acquisitions. The appointment follows Atlantic International's acquisition of Circle8 Group, a leading European IT and technology staffing firm, creating a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenue. The transaction expanded Atlantic's geographic footprint into key European markets and added

    2/2/26 4:05:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

    ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

    6/2/25 1:05:49 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Financials

    Live finance-specific insights

    View All

    Atlantic International Reports Fourth Quarter and Full Year 2025 Results

    ENGLEWOOD CLIFFS, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Following the combination with Circle8 Group, Atlantic is evolving into a scaled, transatlantic workforce solutions platform with a pro forma revenue run-rate exceeding $1 billion, combining U.S. industrial staffing operations with high-margin European technology talent capabilities. Management Commentary and Outlook "In 2025, Atlantic navigated through a transitional period, taking decisive actions to realign our cost structur

    4/16/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Acquires Circle8 Group, Creating a $1.2 Billion Global Workforce Solutions Platform

    ENGLEWOOD CLIFFS, N.J., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing and workforce solutions, today announced the acquisition of Circle8 Group. The transaction creates a diversified global workforce solutions platform with $1.2 billion (unaudited) in annual revenue, uniting Atlantic's North American light industrial staffing operations with Circle8's leading European IT and technology talent business. Acquisition Summary Creates a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenueExpands Atlantic's geographic footprint into key European marketsAdds high-gro

    1/23/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

    Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

    3/28/25 7:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials